{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:15:45Z","timestamp":1794888945758,"version":"4.9.1"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"11","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2022.282528","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T07:44:16Z","timestamp":1682581456000},"page":"3135-3141","source":"Crossref","is-referenced-by-count":10,"title":["&lt;i&gt;TET2&lt;\/i&gt; mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia"],"prefix":"10.3324","volume":"108","author":[{"given":"Violaine Tran","family":"Quang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Podvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Desterke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihem","family":"Tarfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Barathon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouchra","family":"Badaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Freynet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Parinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Leclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Maury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Solary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Selimoglu-Buet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Duployez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orianne","family":"Wagner-Ballon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Sloma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"54017","doi-asserted-by":"crossref","unstructured":"Selimoglu-Buet D, Badaoui B, Benayoun E. Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML. Blood. 2017; 130(6):832-835.","DOI":"10.1182\/blood-2017-04-779579"},{"key":"54018","doi-asserted-by":"crossref","unstructured":"Kasprzak A, Assadi C, Nachtkamp K. Monocytosis at the time of diagnosis has a negative prognostic impact in myelodysplastic syndromes with less than 5% bone marrow blasts. Ann Hematol. 2023; 102(1):99-106.","DOI":"10.1007\/s00277-022-05043-y"},{"key":"54019","doi-asserted-by":"crossref","unstructured":"Calvo X, Garcia-Gisbert N, Parraga I. Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features. Blood Adv. 2020; 4(20):5285-5296.","DOI":"10.1182\/bloodadvances.2020002206"},{"key":"54020","doi-asserted-by":"crossref","unstructured":"Garcia-Gisbert N, Arenillas L, Roman-Bravo D. Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia. Leukemia. 2022; 36(12):2922-2926.","DOI":"10.1038\/s41375-022-01733-8"},{"key":"54021","doi-asserted-by":"crossref","unstructured":"Khoury JD, Solary E, Abla O. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022; 36(7):1703-1719.","DOI":"10.1038\/s41375-022-01613-1"},{"key":"54022","doi-asserted-by":"crossref","unstructured":"Talati C, Zhang L, Shaheen G. Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis. Blood. 2017; 129(13):1881-1883.","DOI":"10.1182\/blood-2016-12-753210"},{"key":"54023","doi-asserted-by":"crossref","unstructured":"Selimoglu-Buet D, Wagner-Ballon O, Saada V. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia. Blood. 2015; 125(23):3618.","DOI":"10.1182\/blood-2015-01-620781"},{"key":"54024","doi-asserted-by":"crossref","unstructured":"Padron E, Painter JS, Kunigal S. GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia. Blood. 2013; 121(25):5068-5077.","DOI":"10.1182\/blood-2012-10-460170"},{"key":"54025","doi-asserted-by":"crossref","unstructured":"Gricourt G, Tran Quang V, Cayuela J-M. Fusion gene detection and quantification by asymmetric capture sequencing (aCAP-Seq). J Mol Diagn. 2022; 24(11):1113-1127.","DOI":"10.1016\/j.jmoldx.2022.07.004"},{"key":"54026","doi-asserted-by":"crossref","unstructured":"Patnaik MM, Timm MM, Vallapureddy R. Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosis. Blood Cancer J. 2017; 7(7):e584-e584.","DOI":"10.1038\/bcj.2017.66"},{"key":"54027","doi-asserted-by":"crossref","unstructured":"Geissler K, J\u00e4ger E, Barna A. Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors. Leukemia. 2016; 30(11):2280-2281.","DOI":"10.1038\/leu.2016.235"},{"key":"54028","doi-asserted-by":"crossref","unstructured":"Geissler K, J\u00e4ger E, Barna A. Correlation of RAS-pathway mutations and spontaneous myeloid colony growth with progression and transformation in chronic myelomonocytic leukemia - a retrospective analysis in 337 patients. Int J Mol Sci. 2020; 21(8):3025.","DOI":"10.3390\/ijms21083025"},{"key":"54029","doi-asserted-by":"crossref","unstructured":"Itzykson R, Kosmider O, Renneville A. Clonal architecture of chronic myelomonocytic leukemias. Blood. 2013; 121(12):2186-2198.","DOI":"10.1182\/blood-2012-06-440347"},{"key":"54030","doi-asserted-by":"crossref","unstructured":"Awada H, Nagata Y, Goyal A. Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia. Blood Adv. 2019; 3(3):339-349.","DOI":"10.1182\/bloodadvances.2018024216"},{"key":"54031","doi-asserted-by":"crossref","unstructured":"Solary E, Wagner-Ballon O, Selimoglu-Buet D. Incorporating flow cytometry and next-generation sequencing in the diagnosis of CMML. Are we ready for prime? Best Pract Res Clin Haematol. 2020; 33(2):101134.","DOI":"10.1016\/j.beha.2019.101134"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282528\/75599","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.282528\/76252","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11069\/75599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:03:59Z","timestamp":1794045839000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.282528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":15,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.282528","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,27]]}}}